Tissue injury induces the expression of various growth factors, cytokines, and chemokines, all of which contribute to tissue repair in a coordinated manner. We previously observed that IL-1 expression increased in corneas treated with alkali.
16 IL-1ra is a member of the IL-1 family and can bind to IL-1 receptors with an affinity similar to that of IL-1α and IL-1β, but it cannot induce signal transduction.
13 15 IL-1s and IL-1ra are expressed simultaneously at wound sites.
31 32 Therefore, the balance between IL-1ra and IL-1 levels in local tissues can determine the physiologic or pathophysiologic effects of IL-1 family members as a whole. Because of its potent antagonistic activities against IL-1s, IL-1ra administration is presumed to be effective in preventing tissue damage. Indeed, topical administration of recombinant IL-1ra can inhibit CNV.
18 However, the role of endogenous IL-1ra in CNV remains unclear. We treated wild-type and IL-1ra KO mice with alkali and observed that CNV was more severe in IL-1ra KO mice. To exclude the possibility that IL-1ra gene ablation may cause additional secondary effects, we administered anti–IL-1ra antibody to WT mice during the course of alkali injury. Antibody-treated WT mice exhibited CNV phenotypes similar to those of IL-1ra KO mice, indicating that aggravated CNV in IL-1ra KO mice was caused by the direct effects of IL-1ra deficiency. These observations further implicate IL-1ra as a potent endogenous antiangiogenic factor in alkali-induced CNV.
Normal corneas lack any vasculature, and physiological corneal avascularity is maintained by the net balance between proangiogenic and antiangiogenic factors.
33 34 35 36 Alkali treatment increased the expression of VEGF, TGF-β, and iNOS, which play crucial roles in ocular neovascularization.
37 38 Among these proangiogenic molecules, VEGF and iNOS expression further increased in IL-1ra KO mice. The expression of a potent antiangiogenic factor, TSP-1, increased to a similar extent in WT and IL-1ra KO mice. Thus, it is plausible that the absence of IL-1ra augmented the expression of proangiogenic molecules, thereby accelerating neovascularization.
IL-1 profoundly affects a number of functions of endothelial cells, such as the production of proinflammatory cytokines, including IL-6, TNF-α, and IL-8, and the expression of adhesion molecules
39 because these cells expressed a large number of high-affinity IL-1 receptors. IL-1ra is expressed in human endothelial cells and atherosclerotic lesions
40 41 and is presumed to exhibit inhibitory effects on the various functions of endothelial cells.
42 Thus, it is likely that the absence of IL-1ra can further directly intensify IL-1–mediated endothelial cell activation and subsequent CNV development.
IL-1 can induce the migration of leukocytes, including macrophages, by enhancing the production of chemokines and the expression of adhesion molecules by endothelial cells. IL-1ra can also antagonize the activities of IL-1.
13 We recently observed that IL-1ra KO mice exhibited neutrophil and macrophage infiltration at skin wound sites to a greater extent than WT mice.
12 In this CNV model, however, the infiltration of macrophages but not neutrophils was exaggerated in IL-1ra KO mice compared with WT mice. These differences may arise from the differences in the anatomic structures between skin and cornea.
Macrophages can be proangiogenic in ocular neovascularization
7 8 9 10 by producing VEGF and iNOS,
43 44 45 key molecules for ocular neovascularization.
37 38 Moreover, Ambati et al.
4 5 reported that corneal neovascularization and VEGF production were suppressed in mice lacking CCR2 and CCR5, the specific chemokine receptors expressed by macrophages. We observed that CX3CR1-expressing macrophages can dampen alkali-induced CNV by producing antiangiogenic factors such as thrombospondin (TSP).
23 Geissmann et al.
46 proposed the dichotomy of macrophages based on the expression levels of CCR2 and CX3CR1. Supporting this assumption, CX3CL1, a ligand for CX3CR1, can induce TSP but not VEGF expression by macrophages in a CX3CR1-dependent manner, whereas CCL2, a ligand for CCR2, can enhance VEGF but not TSP expression by macrophages in a CCR2-dependent manner.
23 IL-1ra can counteract various activities of IL-1s, including the induction of VEGF and iNOS expression by macrophages, and eventually can exhibit antiangiogenic activities. Consistent with previous reports that IL-1ra can be produced by macrophages,
47 48 some but not all F4/80
+ intracorneally infiltrating macrophages expressed IL-1ra. Thus, it is tempting to speculate that CX3CR1-expressing macrophages can also produce IL-1ra, along with TSPs, thereby preventing the development of CNV. If so, the absence of macrophage-derived IL-1ra may augment IL-1–mediated signals and eventually enhance intraocular expression of the major proangiogenic molecules VEGF and iNOS, thereby promoting CNV.